Tähelepanu! Artikkel on enam kui 5 aastat vana ning kuulub väljaande digitaalsesse arhiivi. Väljaanne ei uuenda ega kaasajasta arhiveeritud sisu, mistõttu võib olla vajalik kaasaegsete allikatega tutvumine
Mylan announces appointment of Didier Barret as President- Europe- Middle East and Africa
PITTSBURGH- Oct. 2 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE:
MYL) today announced the appointment of Didier Barret to the
position of President- EMEA (Europe- Middle East and Africa)
following the completion of Mylan's acquisition of Merck's Generics
Group today.
At Merck Generics- M. Barret most recently served as RegionDirector- EMEA- reporting to the CEO. He was promoted to thatposition in 2004 following his role as Area Director for SouthernEurope- where he was responsible for France- Belgium- Italy- Spainand Portugal. He established Merck Generics' first operations inFrance in 1995- growing the business to exceed euro 341 million insales by 2006. Prior to this- M. Barret held several positionswithin Merck's branded division- including sales and marketing inthe UK and France.
Seotud lood
Roojamissagedus on indiviiditi erinev ning normi piirid on avarad. Tervel inimesel võib normaalne olla nii igapäevane sooletegevus kui ka roojamine kolm korda nädalas, eeldusel, et roojamine on pingutuseta ja roe pehme. Anname olulisest ülevaate.
Enimloetud
Viimased uudised
Hetkel kuum
Liitu uudiskirjaga
Telli uudiskiri ning saad oma postkasti päeva olulisemad uudised.
Tagasi Meditsiiniuudised esilehele